Transcriptome Analysis Describing New Immunity and Defense Genes in Peripheral Blood Mononuclear Cells of Rheumatoid Arthritis Patients

Background Large-scale gene expression profiling of peripheral blood mononuclear cells from Rheumatoid Arthritis (RA) patients could provide a molecular description that reflects the contribution of diverse cellular responses associated with this disease. The aim of our study was to identify peripheral blood gene expression profiles for RA patients, using Illumina technology, to gain insights into RA molecular mechanisms. Methodology/Principal Findings The Illumina Human-6v2 Expression BeadChips were used for a complete genome-wide transcript profiling of peripheral blood mononuclear cells (PBMCs) from 18 RA patients and 15 controls. Differential analysis per gene was performed with one-way analysis of variance (ANOVA) and P values were adjusted to control the False Discovery Rate (FDR<5%). Genes differentially expressed at significant level between patients and controls were analyzed using Gene Ontology (GO) in the PANTHER database to identify biological processes. A differentially expression of 339 Reference Sequence genes (238 down-regulated and 101 up-regulated) between the two groups was observed. We identified a remarkably elevated expression of a spectrum of genes involved in Immunity and Defense in PBMCs of RA patients compared to controls. This result is confirmed by GO analysis, suggesting that these genes could be activated systemically in RA. No significant down-regulated ontology groups were found. Microarray data were validated by real time PCR in a set of nine genes showing a high degree of correlation. Conclusions/Significance Our study highlighted several new genes that could contribute in the identification of innovative clinical biomarkers for diagnostic procedures and therapeutic interventions.

[1]  P. Gregersen,et al.  Peripheral blood gene expression profiling in rheumatoid arthritis , 2005, Genes and Immunity.

[2]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[3]  J. Blackwell,et al.  Structure and function of the natural-resistance-associated macrophage protein (Nramp1), a candidate protein for infectious and autoimmune disease susceptibility. , 1996, Molecular medicine today.

[4]  Takaaki Ohtake,et al.  Biology and clinical relevance of naturally occurring antimicrobial peptides. , 2002, The Journal of allergy and clinical immunology.

[5]  The heterogeneity of the glycosylation of alpha-1-acid glycoprotein between the sera and synovial fluid in rheumatoid arthritis. , 2002, Biomedical chromatography : BMC.

[6]  J. Hamilton,et al.  Extravascular coagulation and the plasminogen activator/plasmin system in rheumatoid arthritis. , 2002, Arthritis and rheumatism.

[7]  P. Tak,et al.  Dendritic cells in rheumatoid arthritis: Which subset should be used as a tool to induce tolerance? , 2009, Human immunology.

[8]  P. Rouleau,et al.  The calcium-binding protein S100A12 induces neutrophil adhesion, migration, and release from bone marrow in mouse at concentrations similar to those found in human inflammatory arthritis. , 2003, Clinical immunology.

[9]  W. Venrooij,et al.  Use and significance of anti-CCP autoantibodies in rheumatoid arthritis. , 2006, Rheumatology.

[10]  P. Tobias,et al.  MD-2 binds to bacterial lipopolysaccharide. , 2001, Journal of endotoxin research.

[11]  R N Maini,et al.  Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. , 2000, The New England journal of medicine.

[12]  J. Brock,et al.  Expression of ferritin, transferrin receptor, and non-specific resistance associated macrophage proteins 1 and 2 (Nramp1 and Nramp2) in the human rheumatoid synovium , 2002, Annals of the rheumatic diseases.

[13]  M. Ball,et al.  Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down‐regulation and up‐regulation of apoptotic and pro‐inflammatory signaling , 2002, Journal of neuroscience research.

[14]  Timothy W Behrens,et al.  Gene expression profiling in human autoimmunity , 2006, Immunological reviews.

[15]  D. Foell,et al.  Proinflammatory S100 proteins in arthritis and autoimmune disease. , 2004, Arthritis and rheumatism.

[16]  C. Dinarello,et al.  Interleukin-1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid. , 1986, Arthritis and rheumatism.

[17]  Ji-Young Jang,et al.  Identification of human thioredoxin as a novel IFN-gamma-induced factor: Mechanism of induction and its role in cytokine production , 2008, BMC Immunology.

[18]  S. Akira,et al.  Essential role of MD-2 in LPS responsiveness and TLR4 distribution , 2002, Nature Immunology.

[19]  O Fitzgerald,et al.  Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. , 2003, Rheumatology.

[20]  T. Yoshikawa,et al.  A Critical Role for Allograft Inflammatory Factor-1 in the Pathogenesis of Rheumatoid Arthritis , 2007, The Journal of Immunology.

[21]  A. Achiron,et al.  Gene Expression Studies in Systemic Lupus Erythematosus , 2006, Lupus.

[22]  A. Custovic,et al.  Apoptosis signals in atopy and asthma measured with cDNA arrays , 2001, Clinical and experimental immunology.

[23]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[24]  R. Arceci,et al.  Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection. , 1995, The Journal of clinical investigation.

[25]  J. Yodoi,et al.  Thiordoxin regulates the DNA binding activity of NF-χB by reduction of a disulphid bond involving cysteine 62 , 1992 .

[26]  G. Núñez,et al.  PGLYRP-2 and Nod2 are both required for peptidoglycan-induced arthritis and local inflammation. , 2009, Cell host & microbe.

[27]  F. Ceciliani,et al.  The acute phase protein alpha1-acid glycoprotein: a model for altered glycosylation during diseases. , 2007, Current protein & peptide science.

[28]  J. Korf,et al.  Microarray Profiling of Lymphocytes in Internal Diseases With an Altered Immune Response: Potential and Methodology , 2005, Mediators of inflammation.

[29]  C. Wijbrandts,et al.  Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients , 2007, Annals of the rheumatic diseases.

[30]  Hanlee P. Ji,et al.  The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. , 2006, Nature biotechnology.

[31]  J. Weinberg,et al.  Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. , 1991, Arthritis and rheumatism.

[32]  P. Emery,et al.  Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. , 2004, The New England journal of medicine.

[33]  M. Barnhart,et al.  Fibrin promotion and lysis in arthritic joints. , 1967, Annals of the rheumatic diseases.

[34]  N. Wulffraat,et al.  Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[35]  A. Awomoyi.  The human solute carrier family 11 member 1 protein (SLC11A1): linking infections, autoimmunity and cancer? , 2007, FEMS immunology and medical microbiology.

[36]  S. Brunak,et al.  Blood cell gene expression profiling in rheumatoid arthritis. Discriminative genes and effect of rheumatoid factor. , 2004, Immunology letters.

[37]  C. Libert,et al.  Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. , 2003, Cytokine & growth factor reviews.

[38]  S. Yoshida,et al.  Involvement of thioredoxin in rheumatoid arthritis: its costimulatory roles in the TNF-alpha-induced production of IL-6 and IL-8 from cultured synovial fibroblasts. , 1999, Journal of immunology.

[39]  G. Firestein.  Evolving concepts of rheumatoid arthritis , 2003, Nature.

[40]  L. O’Neill.  Primer: Toll-like receptor signaling pathways—what do rheumatologists need to know? , 2008, Nature Clinical Practice Rheumatology.

[41]  M. Frosch,et al.  Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane. , 1999, The Journal of rheumatology.

[42]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[43]  R. J. Cho,et al.  Transcription, genomes, function. , 2000, Trends in genetics : TIG.

[44]  Hiroaki Kitano,et al.  The PANTHER database of protein families, subfamilies, functions and pathways , 2004, Nucleic Acids Res..

[45]  Bonnie Bruce,et al.  Antigen microarray profiling of autoantibodies in rheumatoid arthritis. , 2005, Arthritis and rheumatism.

[46]  B. Dahlbäck,et al.  The anticoagulant protein C pathway , 2005, FEBS letters.

[47]  I. Boneca.  Mammalian PGRPs in the spotlight. , 2009, Cell host & microbe.

[48]  M. Adams,et al.  Inferring Nonneutral Evolution from Human-Chimp-Mouse Orthologous Gene Trios , 2003, Science.

[49]  F. Cambien,et al.  Performance comparison of two microarray platforms to assess differential gene expression in human monocyte and macrophage cells , 2008, BMC Genomics.

[50]  U. Müller-Ladner,et al.  Molecular profile of synovial fibroblasts in rheumatoid arthritis depends on the stage of proliferation , 2002, Arthritis research.

[51]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[52]  Kevin D. Smith,et al.  The influence of α1‐acid glycoprotein on collagenase‐3 activity in early rheumatoid arthritis , 2003 .

[53]  B. Bresnihan,et al.  Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis. , 2003, Arthritis and rheumatism.

[54]  P. Gregersen,et al.  The genetics revolution and the assault on rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[55]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[56]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Issa J Dahabreh,et al.  Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens. , 2008, Clinical therapeutics.

[58]  P. Tak,et al.  Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis. , 2008, Arthritis and rheumatism.

[59]  Tatiana Tatusova,et al.  NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins , 2004, Nucleic Acids Res..

[60]  Tetsuya Yamagata,et al.  A shared gene‐expression signature in innate‐like lymphocytes , 2006, Immunological reviews.

[61]  M. Feldmann,et al.  Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. , 1991, Arthritis and rheumatism.

[62]  R. Xavier,et al.  Redox signalling and the inflammatory response in rheumatoid arthritis , 2008, Clinical and experimental immunology.

[63]  Maqc Consortium.  The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements , 2006, Nature Biotechnology.

[64]  L. Cardon,et al.  Fine mapping of the MHC Class III region demonstrates association of AIF1 and rheumatoid arthritis. , 2008, Rheumatology.

[65]  L. Staudt,et al.  A library of gene expression signatures to illuminate normal and pathological lymphoid biology , 2006, Immunological reviews.

[66]  M. Brown,et al.  Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis , 2009, Arthritis research & therapy.

[67]  M. Gilliet,et al.  Antimicrobial peptides and self-DNA in autoimmune skin inflammation. , 2008, Current opinion in immunology.

[68]  Michael G. Barnes,et al.  Experimental comparison and cross-validation of the Affymetrix and Illumina gene expression analysis platforms , 2005, Nucleic acids research.

[69]  Y. Kotelevtsev,et al.  Application of gene expression profiling to cardiovascular disease. , 2002, Cardiovascular research.

[70]  F. Macian,et al.  NFAT proteins: key regulators of T-cell development and function , 2005, Nature Reviews Immunology.

[71]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[72]  R. Gay,et al.  The role of Toll-like receptor signalling in the pathogenesis of arthritis. , 2005, Cellular immunology.

[73]  B. Franke,et al.  Gene expression profiling in rheumatoid arthritis: current concepts and future directions , 2008, Annals of the rheumatic diseases.

[74]  E. Nanba,et al.  Human orosomucoid polymorphism: molecular basis of the three common ORM1 alleles, ORM1*F1, ORM1*F2, and ORM1*S , 1997, Human Genetics.

[75]  A. Scheynius,et al.  Truncated thioredoxin (Trx80) induces production of interleukin-12 and enhances CD14 expression in human monocytes. , 2001, Blood.